2-[18F]-FDG PET/CT Semiquantitative and Radiomics Predictive Parameters of Richter's Transformation in CLL Patients

被引:3
|
作者
Albano, Domenico [1 ,2 ]
Calabro, Anna [1 ,2 ]
Dondi, Francesco [1 ,2 ]
Bertagna, Francesco [1 ,2 ]
机构
[1] ASST Spedali Civili Brescia, Nucl Med Unit, I-25123 Brescia, Italy
[2] Univ Brescia, Radiol Sci & Publ Hlth Dept, I-25123 Brescia, Italy
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 02期
关键词
18F-FDG; CLL; PET/CT; Richter transformation; radiomics; CHRONIC LYMPHOCYTIC-LEUKEMIA; TOMOGRAPHY-COMPUTED TOMOGRAPHY;
D O I
10.3390/medicina60020203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in developed countries, which can evolve into aggressive lymphoma variants, a process called Richter transformation (RT). The aim of this retrospective study was to analyze the role of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography(2-[F-18]-FDG PET/CT) and its semiquantitative and radiomics features in detecting RT and evaluate the impact on overall survival (OS).Materials and Methods: One hundred and thirty-seven patients with histologically proven CLL were retrospectively recruited. PET/CT images were qualitativelyand semiquantitatively examined by estimating the main metabolic parameters (the maximum standardized uptake value body weight (SUVbw), lean body mass (SUVlbm), body surface area(SUVbsa), lesion-to-blood-pool SUV ratio (L-BP SUV R), lesion-to-liver SUV ratio (L-L SUV R),metabolic tumor volume (MTV), and total lesion glycolysis (TLG) and radiomics first- and second-order variables of the lesion with highest uptake. The role of these parameters in predicting RT andOS was analyzed.Results: One hundred and thirty (95%) PET/CT scans were positive, showingan increased tracer uptake at the site of disease, whereas the remaining 7 (5%) scans were negative.SUVbw, SUVlbm, SUVbsa, L-L SUV ratio, and L-BP SUV ratio were significantly higher in the RTgroup (p< 0.001 in all cases). Radiomics first- and second-order features were not significantlyassociated with RT. After a median follow-up of 44 months, 56 patients died; OS was significantlyshorter in patients with RT than patients without RT (28 vs. 34 months;p= 0.002). Binet-stage, RT,and L-BP SUV R were shown to be independent prognostic features.Conclusions: SemiquantitativePET/CT parameters such as SUVbw, SUVlbm, SUVbsa, L-L SUV ratio and L-BP SUV ratio may beuseful in discriminating patients with a high risk of developing RT, whereas Binet-stage, RT, andL-BP SUV R are also significant in predicting OS.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prognostic value of haematological parameters and [18F]FDG PET/CT metabolic parameters in head and neck cancer
    Garcia, A. Baena
    de la Torre, J. R. Infante
    Carbonero, R. Barco
    Esteve, A. Martinez
    Barragan, V. Vera
    Vicente, J. Serrano
    Granero, P. Jimenez
    Costero, A. Utrera
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2024, 43 (01): : 31 - 38
  • [42] A prognostication system based on clinical parameters and [18F]-FDG PET/CT in patients with newly diagnosed multiple myeloma
    Li, Junlong
    Zhang, Xiao
    Qin, Chunxia
    Sun, Xun
    Xu, Xiaojun
    Cao, Guoxiang
    Gai, Yongkang
    Sun, Chunyan
    Hu, Yu
    Lan, Xiaoli
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (06) : 1665 - 1670
  • [43] A prognostication system based on clinical parameters and [18F]-FDG PET/CT in patients with newly diagnosed multiple myeloma
    Junlong Li
    Xiao Zhang
    Chunxia Qin
    Xun Sun
    Xiaojun Xu
    Guoxiang Cao
    Yongkang Gai
    Chunyan Sun
    Yu Hu
    Xiaoli Lan
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 1665 - 1670
  • [44] The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
    Gao, Jianxiong
    Niu, Rong
    Shi, Yunmei
    Shao, Xiaoliang
    Jiang, Zhenxing
    Ge, Xinyu
    Wang, Yuetao
    Shao, Xiaonan
    EJNMMI RESEARCH, 2023, 13 (01)
  • [45] The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinoma
    Jianxiong Gao
    Rong Niu
    Yunmei Shi
    Xiaoliang Shao
    Zhenxing Jiang
    Xinyu Ge
    Yuetao Wang
    Xiaonan Shao
    EJNMMI Research, 13
  • [46] The Prognostic and Diagnostic Value of [18F]FDG PET/CT in Untreated Laryngeal Carcinoma
    Al-Ibraheem, Akram
    Abdlkadir, Ahmed Saad
    Al-Adhami, Dhuha
    Abu Hejleh, Taher
    Mansour, Asem
    Mohamad, Issa
    Juweid, Malik E.
    Al-Rasheed, Ula
    Al-Hajaj, Nabeela
    Abu Laban, Dima
    Estrada-Lobato, Enrique
    Saraireh, Omar
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (10)
  • [47] Breast Tumor Characterization Using [18F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics
    Krajnc, Denis
    Papp, Laszlo
    Nakuz, Thomas S.
    Magometschnigg, Heinrich F.
    Grahovac, Marko
    Spielvogel, Clemens P.
    Ecsedi, Boglarka
    Bago-Horvath, Zsuzsanna
    Haug, Alexander
    Karanikas, Georgios
    Beyer, Thomas
    Hacker, Marcus
    Helbich, Thomas H.
    Pinker, Katja
    CANCERS, 2021, 13 (06) : 1 - 18
  • [48] Metabolic Imaging Phenotype Using Radiomics of [18F]FDG PET/CT Associated with Genetic Alterations of Colorectal Cancer
    Shang-Wen Chen
    Wei-Chih Shen
    William Tzu-Liang Chen
    Te-Chun Hsieh
    Kuo-Yang Yen
    Jan-Gowth Chang
    Chia-Hung Kao
    Molecular Imaging and Biology, 2019, 21 : 183 - 190
  • [49] Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin's Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
    Triumbari, Elizabeth Katherine Anna
    Gatta, Roberto
    Maiolo, Elena
    De Summa, Marco
    Boldrini, Luca
    Mayerhoefer, Marius E.
    Hohaus, Stefan
    Nardo, Lorenzo
    Morland, David
    Annunziata, Salvatore
    DIAGNOSTICS, 2023, 13 (08)
  • [50] [18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors
    Wu, Chunhui
    Zhang, Xinhua
    Zeng, Yu
    Wu, Renbo
    Ding, Li
    Xia, Yanzhe
    Chen, Zhifeng
    Zhang, Xiangsong
    Wang, Xiaoyan
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 50 (01) : 194 - 204